We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Reusing Pacemakers from Deceased Donors Is Safe

By HospiMedica International staff writers
Posted on 21 Dec 2011
Permanent pacemakers (PPMs) donated by funeral homes in the United States can be safely and effectively reused, according to a new study. More...


Researchers at Loyola University Medical Center (Maywood, IL, USA) and the University of Texas-Health Science Center (Houston, TX, USA) examined the function of 121 donated PPMs that were sterilized and sent for implantation in needy and indigent patients at a charity hospital in Mumbai (India). From the pool of donated 121 PPMs, 53 were acceptable for reuse and implanted in corresponding patients (mean age 64 years, 53% women). The indications for PPM implantation were complete heart block and sick sinus syndrome.

The researchers found that all the patients were alive and well postoperatively. No significant complications, including infections or device failures, occurred during an average two years of follow-up. All but two patients reported marked improvement in their symptoms. Of the 40 patients (75%), who were followed locally, 4 died due to nonpacemaker-related causes; time to death was a mean 430 days after PPM implantation. While there were only four patients (8%) who were previously employed, all were able to resume their manual labor work. Of the women, 27 patients (96%) reported improvement in symptoms enabling them to resume regular household chores after PPM implantation. The study was published online ahead of print on October 12, 2011, in the American Journal of Cardiology.

“Without pacemakers, these patients would pretty much be forced to remain on confined rest, due to cardiac fatigue,” concluded lead author Gaurav Kulkarni, MD, of Loyola University Medical Center, and colleagues. “Reusing pacemakers could alleviate the burden of symptomatic bradyarrhythmia in impoverished nations around the world.”

The US Food and Drug Administration (FDA) forbids the implantation of used pacemakers within the United States and severely questions its safety, calling it an objectionable practice due to potential sterilization issues, especially in the terminals. There are no federal prohibitions, however, on harvesting used pacemakers for implantation abroad. In India, a new pacemaker costs USD 2,200 to USD 6,600, well beyond the means of many patients.

Related Links:
Loyola University Medical Center
University of Texas-Health Science Center



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.